1330738-58-3

Upstream product

• 747414-22-8 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-4-iodoisoxazole-3-carboxylic acid ethylamide 
• 1330736-56-5 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-4-cyano-N-ethylisoxazole-3-carboxamide 

Downstream Products

• 1330739-54-2 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(5-hydroxy-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide 
• 1330738-60-7 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide 
• 1330739-64-4 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(5-mercapto-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide 
• 1330738-97-0 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide 
• 1330739-82-6 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(5-methoxy-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide 

Relevant academic research and scientific papers

A NOVEL 5-MEMBERED HETEROCYCLE DERIVATIVES AND MANUFACTURING PROCESS THEREOF

Disclosed herein are a novel 5-membered heterocycle derivatives represented by Formula I, a tautomer, pharmaceutically approved salts thereof, prodrug of this compound, or pharmaceutically use. Accordingly this prevent invention, a novel 5-membered heterocycle derivatives, a tautomer, pharmaceutically approved salt, or prodrug show antitumoral activity. Thus, this compounds are useful in the treatment of tumor.